Manuel Villegas Roberson
@villrob.bsky.social
IM PGY-4 Chief Resident. Interested in PCCM 🫁 🏳️🌈 🎾
Reposted by Manuel Villegas Roberson
Associated secondary analysis here: Aetiology of sepsis in adults living with HIV in East Africa: a secondary analysis of an open-label, multicentre, randomised, controlled phase 3 trial - eClinicalMedicine www.thelancet.com/journals/ecl...
Aetiology of sepsis in adults living with HIV in East Africa: a secondary analysis of an open-label, multicentre, randomised, controlled phase 3 trial
Mtb was the most common pathogen causing sepsis and bloodstream infection and was
frequently missed by conventional rapid diagnostics. We also identified a high prevalence
of non-mycobacterial pathoge...
www.thelancet.com
January 31, 2026 at 3:42 AM
Associated secondary analysis here: Aetiology of sepsis in adults living with HIV in East Africa: a secondary analysis of an open-label, multicentre, randomised, controlled phase 3 trial - eClinicalMedicine www.thelancet.com/journals/ecl...
Reposted by Manuel Villegas Roberson
🔥🔥🔥 HOT OF THE PRESS!🔥🔥🔥
Immediate or high-dose antituberculosis therapy for HIV-related sepsis in Tanzania and Uganda (ATLAS): a phase 3, open-label, randomised, controlled, 2 × 2 factorial, superiority trial - The Lancet Infectious Diseases www.thelancet.com/journals/lan...
Immediate or high-dose antituberculosis therapy for HIV-related sepsis in Tanzania and Uganda (ATLAS): a phase 3, open-label, randomised, controlled, 2 × 2 factorial, superiority trial - The Lancet Infectious Diseases www.thelancet.com/journals/lan...
January 31, 2026 at 3:37 AM
🔥🔥🔥 HOT OF THE PRESS!🔥🔥🔥
Immediate or high-dose antituberculosis therapy for HIV-related sepsis in Tanzania and Uganda (ATLAS): a phase 3, open-label, randomised, controlled, 2 × 2 factorial, superiority trial - The Lancet Infectious Diseases www.thelancet.com/journals/lan...
Immediate or high-dose antituberculosis therapy for HIV-related sepsis in Tanzania and Uganda (ATLAS): a phase 3, open-label, randomised, controlled, 2 × 2 factorial, superiority trial - The Lancet Infectious Diseases www.thelancet.com/journals/lan...
Join us for the exciting session we’re about to have next Monday at #CHEST2025. Honored to moderate this insightful presentation with an amazing group of faculty.
October 15, 2025 at 3:43 PM
Join us for the exciting session we’re about to have next Monday at #CHEST2025. Honored to moderate this insightful presentation with an amazing group of faculty.
Reposted by Manuel Villegas Roberson
🌲 COMING UP THIS MONDAY🌲
🚨 Don’t miss the PINE Webinar on the NEW TB treatment guidelines!
🦠 Big updates. Expert insights. Sign up today!
#TB #GlobalHealth #MedSky #PCCMSky
@ats-assemblies.bsky.social @idsainfo.bsky.social @btsrespiratory.bsky.social @theunion.org
🚨 Don’t miss the PINE Webinar on the NEW TB treatment guidelines!
🦠 Big updates. Expert insights. Sign up today!
#TB #GlobalHealth #MedSky #PCCMSky
@ats-assemblies.bsky.social @idsainfo.bsky.social @btsrespiratory.bsky.social @theunion.org
🔥 !COMING SOON! 🔥 Drs. Saukkonen & Daly will unpack the 2025 ATS/CDC/ERS/IDSA TB guidelines in this newest🌲PINE🌲 webinar!
📅 July 21 | 12 PM ET
🔗 Register here: bit.ly/446PvCv
@atscommunity.bsky.social
@ats-assemblies.bsky.social
@idsainfo.bsky.social
@theunion.org
@btsrespiratory.bsky.social
📅 July 21 | 12 PM ET
🔗 Register here: bit.ly/446PvCv
@atscommunity.bsky.social
@ats-assemblies.bsky.social
@idsainfo.bsky.social
@theunion.org
@btsrespiratory.bsky.social
July 16, 2025 at 9:05 PM
🌲 COMING UP THIS MONDAY🌲
🚨 Don’t miss the PINE Webinar on the NEW TB treatment guidelines!
🦠 Big updates. Expert insights. Sign up today!
#TB #GlobalHealth #MedSky #PCCMSky
@ats-assemblies.bsky.social @idsainfo.bsky.social @btsrespiratory.bsky.social @theunion.org
🚨 Don’t miss the PINE Webinar on the NEW TB treatment guidelines!
🦠 Big updates. Expert insights. Sign up today!
#TB #GlobalHealth #MedSky #PCCMSky
@ats-assemblies.bsky.social @idsainfo.bsky.social @btsrespiratory.bsky.social @theunion.org
First Bluesky post to celebrate the awesome discussion we had today on pulmonary rehabilitation. So many great and innovative insights to share! #ATS2025
May 21, 2025 at 6:43 AM
First Bluesky post to celebrate the awesome discussion we had today on pulmonary rehabilitation. So many great and innovative insights to share! #ATS2025